Isaac Francis

Incyte (NASDAQ:INCY) said it has completed the acquisition of Vega Therapeutics, a subsidiary of Star Therapeutics, in a transaction valued at $1.25 billion upfront.

Ondas Holdings (NASDAQ:ONDS) said it has entered into an agreement to acquire DZYNE Technologies in a transaction valued at approximately $875.8 million in cash and stock.

Pharvaris (NASDAQ:PHVS) announced the FDA accepted its regulatory application for its 20 mg hereditary angioedema on-demand treatment capsule.

Natera (NASDAQ:NTRA) announced publication of new clinical data in JAMA Oncology evaluating its Signatera molecular residual disease (MRD) test in patients with resected colorectal liver metastases (CRLM).

Molecular Partners (NASDAQ:MOLN) said its Phase 1/2a U.S. study of MP0712 is actively dosing patients in a trial targeting DLL3-positive small cell lung cancer and neuroendocrine tumors.

Venus Metals (ASX:VMC) discovered an anomalous gold target zone measuring 1600m by 450m at its Henderson Project.

Adjusted stablecoin transaction volume reached a record US$1.79 trillion in June, up 63% from US$1.10 trillion in May and 125% higher than a year earlier, according to Visa's Allium-powered analytics dashboard.

European central bankers and regulators warned that rapid advances in agentic artificial intelligence could increase financial market risks, with the Bank of England raising the prospect of safeguards similar to trading circuit breakers.

Strategy Executive Chairman Michael Saylor said Bitcoin (CRYPTO:BTC) is entering a new phase of adoption in which its primary role will shift from a buy-and-hold asset to digital capital supporting lending.

Helia Group (ASX:HLI) secured an exclusive four-year lenders mortgage insurance contract with ING Bank Australia starting in July.